P2 purinoceptor-mediated cardioprotection in ischemic-reperfused mouse heart

Journal of Pharmacology and Experimental Therapeutics

Volumn 323, Issue 3, 2007, Pages 861-867

  Wee, Shirley ^a   Peart, Jason N ^a   Headrick, John P ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; LACTATE DEHYDROGENASE; MRS 2159; PURINE P2 RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL ALPHA5 PHOSPHATE 6 PHENYLAZO 4' CARBOXYLIC ACID; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME RELEASE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE PRESSURE; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARDIOTONIC AGENTS; CELL DEATH; MALE; MICE; MICE, INBRED C57BL; MICRODIALYSIS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NUCLEOTIDES; PERFUSION; RECEPTORS, PURINERGIC P2;

EID: 36349032386     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.125815     Document Type: Article

References (38)

1. Burnstock G and Kennedy C (1986) Purinergic receptors in the cardiovascular system. Prog Pharmacol 6:111-132.
2. Chen BC, Lee CM, and Lin WW (1996) Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages. Br J Pharmacol 119:1628-1634.
3. Clemens MG and Forrester T (1980) Appearance of adenosine triphosphate in the coronary sinus effluent from isolated working rat heart in response to hypoxia. J Physiol 312:143-158.
4. Corr L and Burnstock G (1991) Vasodilator response of coronary smooth muscle to the sympathetic co-transmitters noradrenaline and adenosine 5′-triphosphate. Br J Pharmacol 104:337-342.
5. Eckle T, Grenz A, Faigle M, Weissmuller T, Thompson L, Colgan SP, Oßwald H, and Eltzschig HK (2006) Critical role of 5′- ectonucleotidase (CD73) in cardiac ischemic preconditioning (Abstract). Purinergic Signal 2:164.
6. Forrester T and Williams CA (1977) Release of adenosine triphosphate from isolated adult heart cells in response to hypoxia. J Physiol 268:371-390.
7. Harrison GJ, Willis RJ, and Headrick JP (1998) Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc Res 40:74-87.
8. Headrick JP, Peart J, Hack B, Flood A, and Matherne GP (2001) Functional properties and responses to ischemia reperfusion in Langendorff perfused mouse hearts. Exp Physiol 86:703-716.
9. Headrick JP and Willis RJ (1989) 5′-Nucleotidase activity and adenosine formation in stimulated, hypoxic and underperfused rat heart. Biochem J 261:541-550.
10. Hill BJF and Sturek M (2002) Pharmacological characterization of a UTP-sensitive P2Y nucleotide receptor in organ cultured coronary arteries. Vasc Pharmacol 39:83-88.
11. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
12. Jacobson KA, Jarvis MF, and Williams M (2002) Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 45:4057-4093.
13. Kunapuli SP and Daniel JL (1998) P2 receptor subtypes in the cardiovascular system. Biochem J 336:513-523.
14. 6 receptor mediated contractions in human cerebral arteries. BMC Pharmacol 3:4.
15. i responses. Am J Physiol 281:H1759- H1766.
16. Matsumoto T, Nakane T, and Chiba S (1997) UTP induces vascular responses in the isolated and perfused canine epicardial coronary artery via UTP-preferring P2Y receptors. Br J Pharmacol 122:1625-1632.
17. i3. J Biol Chem 273:4695-4704.
18. Ninomiya H, Otani H, Lu K, Uchiyama T, Kido M, and Imamura H (2002a) Complementary role of extracellular ATP and adenosine in ischemic preconditioning in the rat heart. Am J Physiol Heart Circ Physiol 282:H1810-H1820.
19. Ninomiya H, Otani H, Lu K, Uchiyama T, Kido M, and Imamura H (2002b) Enhanced IPC by activation of pertussis toxin-sensitive and -insensitive G protein-coupled purinoceptors. Am J Physiol 282:H1933-1943.
20. 1 mediates t-PA release in pigs during cardiac ischemia. J Thromb Thrombolysis 24:115-122.
21. 1 adenosine receptors during ischemia and reperfusion improves ischemic tolerance. Am J Physiol 279:H2166-H2175.
22. Peart J and Headrick JP (2003) Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects. Cardiovasc Res 58:589-601.
23. Rayment SJ, Latif ML, Ralevic V, and Alexander SP (2007) Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in porcine isolated arteries. Br J Pharmacol 150:604-612.
24. 1 adenosine receptor limits myocardial ischemic tolerance. Circ Res 96:363-367.
25. 2-+ transients in human coronary artery smooth muscle cells. Br J Pharmacol 118:1645-1652.
26. Sugimura A, Kanatsuka H, Tanikawa T, Ong BH, and Shirato K (2000) Effect of diadenosine tetraphosphate (AP4A) on coronary arterial microvessels in the beating canine heart. Jpn Circ J 64:868-875.
27. Vassort G (2001) Adenosine 5′-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 81:767-806.
28. Vials AJ and Burnstock G (1994) Differential effects of ATP- and 2-methylthioATP-induced relaxation in guinea pig coronary vasculature. J Cardiovasc Pharmacol 23:757-764.
29. von Kügelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110:415-432.
30. von Kügelgen I and Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 362:310-323.
31. Wang LW, Karlsson L, Moses S, Hultgardh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, and Erlinge D (2002) P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40:841-853.
32. Webb TE, Boluyt MO, and Barnard EA (1996) Molecular biology of P2Y purinoceptors: expression in rat heart. J Auton Pharmacol 16:303-307.
33. 6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res 98:970-976.
34. Yang S, Cheek YS, Westfall DP, and Buxton IL (1994) Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res 74:401-407.
35. Yegutkin GG and Burnstock G (2000) Inhibitory effects of some purinergic agents on ecto-ATPase activity and pattern of stepwise ATP hydrolysis in rat liver plasma membranes. Biochim Biophys Acta 1466:234-244.
36. Yitzhaki S, Shainberg A, Cheporko Y, Vidne BA, Sagie A, Jacobson KA, and Hochhauser E (2006) Uridine-5′-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarct. Biochem Pharmacol 72:949-955.
37. Yitzhaki S, Shneyvays V, Jacobson KA, and Shainberg A (2005) Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress. Biochem Pharmacol 69:1215-1223.
38. Zheng JS, O'Neill L, Long X, Webb TE, Barnard EA, Lakatta EG, and Boluyt MO (1998) Stimulation of P2Y receptors activates c-fos gene expression and inhibits DNA synthesis in cultured cardiac fibroblasts. Cardiovasc Res 37:718-728.